Pharmafile Logo

Claire Long

- PMLiVE

The big picture

Cost talks should go hand-in-hand with value discussions

Heart failure therapy embarks on a new era

After years of older, generic drugs, now new treatments are showing promising results

- PMLiVE

Challenging perceptions

Alvaro Herreros on the ADHD landscape

Not as we know it

We shouldn’t expect our descendants to look like us

- PMLiVE

Amgen’s roll-out of myeloma drug Kyprolis reaches UK

Company hopes to gain NICE approval later this year

- PMLiVE

Researchers say ‘neurostatins’ may ward off Alzheimer’s

Preclinical studies show bexarotene prevents nerve cell degeneration

- PMLiVE

Reading may save your life

The importance of health literacy

- PMLiVE

Communicating health messages

How studies are presented often determines whether they resonate

- PMLiVE

Forging a path in specialty care

Takeda’s Marc Princen on the company’s plans to build a reputation in oncology, gastroenterology and vaccine

Changing faces – overcoming the taboo of marketing to a mature audience

Our new blog highlights the challenges for communicating to consumers who are 50+ and how they must be tackled in order to create marketing opportunities.

Say Communications

- PMLiVE

Merck and Sun Pharma part company on branded generics

Will continue partnership on diabetes and inflammatory disorder projects

Eli Lilly HQ

UK court backs Actavis in dispute over Lilly’s Alimta

Actavis’ generic version ruled not to infringe Lilly’s intellectual property

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links